Change in Working Capital

-$668.50M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$668.50Mperiod endingJun 30, 2026

VRTX Change in Working Capital ($800.00K → -$668.50M)

Annual change in working capital

High-resolution chart · PNG

VRTX change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	-1,199,100,000
Dec 31, 2024	-514,800,000
Dec 31, 2023	-265,700,000
Dec 31, 2022	340,800,000
Dec 31, 2021	-105,200,000
Dec 31, 2020	-54,454,000
Dec 31, 2019	-66,101,000
Dec 31, 2018	238,020,000
Dec 31, 2017	15,264,000
Dec 31, 2016	-2,070,000
Dec 31, 2015	-85,950,000
Dec 31, 2014	-11,063,000
Dec 31, 2013	-5,051,000
Dec 31, 2012	-13,788,000
Dec 31, 2011	-193,064,000
Dec 31, 2010	-63,777,000
Dec 31, 2009	61,424,000
Dec 31, 2008	138,783,000
Dec 31, 2007	47,300,000
Dec 31, 2006	123,054,000
Dec 31, 2005	-52,073,000
Dec 31, 2004	-12,741,000
Dec 31, 2003	68,944,000
Dec 31, 2002	867,000
Dec 31, 2001	41,090,000
Dec 31, 2000	9,789,000
Dec 31, 1999	1,500,000
Dec 31, 1998	-1,900,000
Dec 31, 1997	6,900,000
Dec 31, 1996	-3,300,000
Dec 31, 1995	1,900,000
Dec 31, 1994	-600,000
Dec 31, 1993	2,700,000
Dec 31, 1992	400,000
Dec 31, 1991	800,000